Bevacizumab in the treatment of patients with advanced breast cancer: where have we landed?

Por Dirix, L. Y., Van Dam, P. A., Prove, A. M., Vermeulen, P. B.
Publicado em 2010

Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature

Por Pelgrims, J, Vos, F De, Brande, J Van den, Schrijvers, D, Prové, A, Vermorken, J B
Publicado em 2000

Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer

Por Dirix, L Y, Salgado, R, Weytjens, R, Colpaert, C, Benoy, I, Huget, P, van Dam, P, Prové, A, Lemmens, J, Vermeulen, P
Publicado em 2002

Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT–PCR in patients with metastatic breast cancer

Por Van der Auwera, I, Peeters, D, Benoy, I H, Elst, H J, Van Laere, S J, Prové, A, Maes, H, Huget, P, van Dam, P, Vermeulen, P B, Dirix, L Y
Publicado em 2010

Circulating tumour cells in the central and the peripheral venous compartment in patients with metastatic breast cancer

Por Peeters, D J E, Van den Eynden, G G, van Dam, P-J, Prové, A, Benoy, I H, van Dam, P A, Vermeulen, P B, Pauwels, P, Peeters, M, Van Laere, S J, Dirix, L Y
Publicado em 2011